|
|
||||||||


* Division of Trauma Surgery and
Department of Pathology, University Hospital Zurich, CH-8091 Zurich, Switzerland; and
Department of Biochemical Pharmacology, University of Konstanz, D-78457 Konstanz, Germany
1Correspondence: Division of Trauma Surgery, University Hospital Zurich, Raemistr. 100, CH-8091 Zurich, Switzerland. E-mail: guido.wanner{at}chi.usz.ch
Using a murine model, we studied the effect of agonistic anti-CD95 antibodies (aCD95) on sinusoidal lining cells and a potential protection by caspase inhibition. C3H/HeN mice were intravenously administered aCD95 (10 µg/mouse) or unspecific IgG (control) in the presence or absence of the caspase inhibitor z-VAD-fmk. Analysis of hepatic microcirculation using intravital fluorescence microscopy revealed severe (P<0.01) sinusoidal perfusion failure and reduced (P<0.05) phagocytic activity of Kupffer cells (KC) within 2 h. Transmission electron micrographs demonstrated loss of integrity of sinusoidal endothelial cells as early as 1 h after aCD95 application, whereas histological manifestation of hepatocellular apoptosis and hemorrhagic necrosis was most pronounced at 6 h. Blocking of caspase activity attenuated (P<0.01) both hepatic microvascular perfusion failure and KC dysfunction. Accordingly, full protection of the liver from apoptotic damage and intact microarchitecture was observed in histological sections after z-VAD-fmk treatment. Mortality rate was 40% 6 h after aCD95 administration, whereas all animals survived in the z-VAD-fmk group (P<0.05). The activation of caspases through CD95 may primarily lead to damage of sinusoidal endothelial cells and hepatic microvascular perfusion failure. Moreover, reduced phagocytic capacity of KC may contribute to accumulation of toxic metabolites released by dying cells at the local site of inflammation, further aggravating liver injury.Wanner, G. A., Mica, L., Wanner-Schmid, E., Kolb, S. A., Hentze, H., Trentz, O., Ertel, W. Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity.
Key Words: liver failure apoptosis hepatic microcirculation cysteine protease
This article has been cited by other articles:
![]() |
N. Ohi, Y. Nishikawa, T. Tokairin, Y. Yamamoto, Y. Doi, Y. Omori, and K. Enomoto Maintenance of Bad Phosphorylation Prevents Apoptosis of Rat Hepatic Sinusoidal Endothelial Cells in Vitro and in Vivo Am. J. Pathol., April 1, 2006; 168(4): 1097 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ashare, M. M. Monick, L. S. Powers, T. Yarovinsky, and G. W. Hunninghake Severe Bacteremia Results in a Loss of Hepatic Bacterial Clearance Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 644 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Spierings, E. G. de Vries, E. Vellenga, F. A. van den Heuvel, J. J. Koornstra, J. Wesseling, H. Hollema, and S. de Jong Tissue Distribution of the Death Ligand TRAIL and Its Receptors J. Histochem. Cytochem., June 1, 2004; 52(6): 821 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Eipel, R. Bordel, R. M. Nickels, M. D. Menger, and B. Vollmar Impact of leukocytes and platelets in mediating hepatocyte apoptosis in a rat model of systemic endotoxemia Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G769 - G776. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khandoga, A. Stampfl, S. Takenaka, H. Schulz, R. Radykewicz, W. Kreyling, and F. Krombach Ultrafine Particles Exert Prothrombotic but Not Inflammatory Effects on the Hepatic Microcirculation in Healthy Mice In Vivo Circulation, March 16, 2004; 109(10): 1320 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bang, M. Biburger, W. L. Neuhuber, and G. Tiegs Neurokinin-1 Receptor Antagonists Protect Mice from CD95- and Tumor Necrosis Factor-{alpha}-Mediated Apoptotic Liver Damage J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1174 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, A. J. Szalai, T. Zhou, K. R. Zinn, T. R. Chaudhuri, X. Li, W. J. Koopman, and R. P. Kimberly Fc{gamma}Rs Modulate Cytotoxicity of Anti-Fas Antibodies: Implications for Agonistic Antibody-Based Therapeutics J. Immunol., July 15, 2003; 171(2): 562 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zender, S. Hutker, C. Liedtke, H. L. Tillmann, S. Zender, B. Mundt, M. Waltemathe, T. Gosling, P. Flemming, N. P. Malek, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice PNAS, June 24, 2003; 100(13): 7797 - 7802. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. SCHAFER, C. SCHEUER, K. ROEMER, M. D. MENGER, and B. VOLLMAR Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death FASEB J, April 1, 2003; 17(6): 660 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jodo, J. T. Kung, S. Xiao, D. V. Chan, S. Kobayashi, M. Tateno, R. Lafyatis, and S.-T. Ju Anti-CD95-induced Lethality Requires Radioresistant Fcgamma RII+ Cells. A NOVEL MECHANISM FOR FULMINANT HEPATIC FAILURE J. Biol. Chem., February 21, 2003; 278(9): 7553 - 7557. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vermijlen, D. Luo, C. J Froelich, J. P. Medema, J. A. Kummer, E. Willems, F. Braet, and E. Wisse Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway J. Leukoc. Biol., October 1, 2002; 72(4): 668 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Janin, C. Deschaumes, M. Daneshpouy, J. Estaquier, J. Micic-Polianski, P. Rajagopalan-Levasseur, K. Akarid, N. Mounier, E. Gluckman, G. Socie, et al. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications Blood, April 15, 2002; 99(8): 2940 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Bajt, J. A. Lawson, S. L. Vonderfecht, J. S. Gujral, and H. Jaeschke Protection against Fas Receptor-Mediated Apoptosis in Hepatocytes and Nonparenchymal Cells by a Caspase-8 Inhibitor in Vivo: Evidence for a Postmitochondrial Processing of Caspase-8 Toxicol. Sci., November 1, 2000; 58(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |